Patient 2
Case2: Female, 28 years old, ethnicity not specified
DiseaseAssertion: Glanzmann thrombasthenia type 1
FamilyInfo: N/A
ParentalGenotype: Parents were heterozygous for this mutation and did not show bleeding symptoms
Note: There is parental consanguinity
CasePresentingHPOs: N/A
CaseHPOFreeText: Severe haemorrhagia and haematomas associated with prolonged in vivo bleeding time
CaseNotHPOs: N/A
CaseNotHPOsFreeText: N/A
ProteinExpression: Flow cytometry analysis revealed 3.5 % of αIIbβ3 was detected on the platelet surface from patient 2.
PlateletAggregation: Article states agonist-induced platelet aggregation and binding of exogenous fibrinogen was pathological, too but does not mention specific agonists used or response to ristocetin
CasePreviousTesting: Molecular genetic analysis was done; however, no other information mentioned. In addition, the global proteome of highlight purified washed platelets was quantified by liquid chromatography-mass spectrometry and targeted MS-methods.
Gene: ITGA2B
Variant: NM_000419.3:c.2374del
LegacyVariant: N/A
ClinVar: N/A
CAiD: CA915940267
gnomAD: N/A